An illness by any other name: The effect of renaming gout on illness and treatment perceptions. KJ Petrie, K MacKrill, C Derksen, N Dalbeth Health Psychology 37 (1), 37, 2018 | 28 | 2018 |
What is associated with increased side effects and lower perceived efficacy following switching to a generic medicine? A New Zealand cross-sectional patient survey K MacKrill, KJ Petrie BMJ open 8 (10), e023667, 2018 | 26 | 2018 |
Evidence of a media-induced nocebo response following a nationwide antidepressant drug switch K MacKrill, GD Gamble, DJ Bean, T Cundy, KJ Petrie Clinical Psychology in Europe 1 (1), 1-12, 2019 | 25 | 2019 |
What makes an idea worth spreading? Language markers of popularity in TED talks by academics and other speakers K MacKrill, C Silvester, JW Pennebaker, KJ Petrie Journal of the Association for Information Science and Technology 72 (8 …, 2021 | 16 | 2021 |
The effect of symptom‐tracking apps on symptom reporting K MacKrill, KM Groom, KJ Petrie British Journal of Health Psychology 25 (4), 1074-1085, 2020 | 16 | 2020 |
Impact of media coverage on side effect reports from the COVID-19 vaccine K MacKrill Journal of psychosomatic research 164, 111093, 2023 | 11 | 2023 |
Increasing and dampening the nocebo response following medicine-taking: a randomised controlled trial K MacKrill, Z Morrison, KJ Petrie Journal of Psychosomatic Research 150, 110630, 2021 | 10 | 2021 |
The effect of television and print news stories on the nocebo responding following a generic medication switch K MacKrill, GD Gamble, KJ Petrie Clinical Psychology in Europe 2 (2), 2020 | 10 | 2020 |
Characteristics of individuals who prefer branded innovator over generic medicines: A New Zealand general population survey M Kleinstäuber, K MacKrill, KJ Petrie Drugs & Therapy Perspectives 34, 478-483, 2018 | 9 | 2018 |
When symptoms become side effects: Development of the side effect attribution scale (SEAS) K MacKrill, R Webster, GJ Rubin, M Witthöft, C Silvester, Y Emad, ... Journal of psychosomatic research 141, 110340, 2021 | 7 | 2021 |
OK Computer? A time analysis of Google searches about symptoms KJ Petrie, K MacKrill, C Silvester, GD Gamble, N Dalbeth, JW Pennebaker Clinical Psychology in Europe 1 (2), 1-10, 2019 | 7 | 2019 |
The effect of rebranding generic medicines on drug efficacy and side effects K MacKrill, M Kleinstäuber, KJ Petrie Psychology & Health 34 (12), 1470-1485, 2019 | 5 | 2019 |
The impact of the illness label ‘gout’on illness and treatment perceptions in Māori (Indigenous New Zealanders) N Dalbeth, M Douglas, K MacKrill, L Te Karu, M Kleinstäuber, KJ Petrie BMC rheumatology 4, 1-6, 2020 | 3 | 2020 |
Conducting a correlational study using publicly available data to investigate a nationwide nocebo effect K MacKrill, KJ Petrie SAGE Publications Limited, 2020 | 2 | 2020 |
Improving the understanding and measurement of the nocebo effect KM MacKrill PhD Thesis-University of Auckland, 2021 | 1 | 2021 |
Mass Hysteria R Bartholomew, K MacKrill Reference Module in Neuroscience and Biobehavioral Psychology, 2020 | 1* | 2020 |
Health Scares: Tracing Their Nature, Growth and Spread K MacKrill, M Witthöft, S Wessely, KJ Petrie Clinical Psychology in Europe 5 (4), 2023 | | 2023 |
The Nocebo Effect KJ Petrie, K MacKrill Cambridge Handbook of Psychology, Health and Medicine, 97-100, 2019 | | 2019 |
WHAT CHARACTERIZES INDIVIDUALS WHO PREFER BRANDED OVER GENERIC MEDICINE? M Kleinstaeuber, K MacKrill, KJ Petrie INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE 25, S48-S49, 2018 | | 2018 |
PSYCHOLOGICAL PREDICTORS OF PATIENT CONCERN AND ITS EFFECTS IN MEDICINE BRAND CHANGES K MacKrill, K Petrie INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE 25, S41-S42, 2018 | | 2018 |